Company intelligence / Profile preview

BrainSpec

Boston, Massachusetts, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

BrainSpec is a health technology company that provides a web-based software platform for non-invasive brain chemistry analysis. Utilizing Magnetic Resonance Spectroscopy (MRS), the platform processes raw data from MRI scanners to measure metabolite levels in the brain, offering a virtual biopsy for clinicians. This technology assists in the diagnosis and monitoring of various neurological conditions, including brain tumors, Alzheimer's disease, and traumatic brain injury. By automating the complex processing of MRS data, BrainSpec aims to make advanced neuroimaging more accessible and actionable in clinical practice.

Therapeutic areas: OncologyNeurologyPsychiatry
Modalities: DeviceSoftware
Industry: Metabolite Diagnostics

Partnerships

GE HealthCareSiemens HealthineersPhilips

Beyond the preview

Go deeper on BrainSpec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BrainSpec.

Explore the full profile